Age-related changes in oxidized proteins.
We have previously described the oxidative inactivation of several key metabolic enzymes by a variety of mixed function oxidation systems. Because many of the enzymes which are inactivated have been shown by others to accumulate as inactive or less active forms during cellular aging, we have examined the levels of oxidatively modified proteins in two model systems used for studies on aging. The results show that levels of oxidatively modified proteins increase with age in circulating erythrocytes, and this change is correlated with the loss of marker enzyme activity. Our studies also show that in cultured fibroblasts from normal donors the levels of oxidatively modified proteins increase only after the age of 60. However, the levels of oxidatively modified proteins in fibroblasts from individuals with progeria or Werner's syndrome are significantly higher than age-matched controls. Moreover, treatment of glucose-6-phosphate dehydrogenase with a mixed function oxidation system leads to oxidative modification and increased heat lability of the enzyme. Taken together these results suggest that loss of functional enzyme activity and increased heat lability of enzymes during aging may be due in part to oxidative modification by mixed function oxidation systems.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging; D001219:Aspartate Aminotransferases / Q000097:blood*; D002460:Cell Line; D002648:Child; D002675:Child, Preschool; D004795:Enzyme Stability; D004905:Erythrocyte Aging; D004912:Erythrocytes / Q000201:enzymology*; D005260:Female; D005993:Glycerolphosphate Dehydrogenase / Q000097:blood*; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D010084:Oxidation-Reduction; D010735:Phosphoglycerate Kinase / Q000097:blood*
D006899:Mixed Function Oxygenases; D005993:Glycerolphosphate Dehydrogenase; D001219:Aspartate Aminotransferases; D010735:Phosphoglycerate Kinase